In this episode, we are featuring Kiora Pharmaceuticals (Nasdaq: KPRX), a clinical-stage biotechnology company developing advanced therapies for retinal disease.

This interview is moderated by Robert Blum, Managing Partner at Lytham Partners, and features Brian Strem, President & CEO at Kiora.